↓ Skip to main content

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study

Overview of attention for article published in BMC Neurology, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
56 Mendeley